These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34694241)

  • 1. Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials.
    Abdelmonem M; Ebada MA; Diab S; Ahmed MM; Zaazouee MS; Essa TM; ElBaz ZS; Ghaith HS; Abdella WS; Ebada M; Negida A
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e64-e74. PubMed ID: 34694241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials.
    Serban C; Sahebkar A; Ursoniu S; Andrica F; Banach M
    J Hypertens; 2015 Jun; 33(6):1119-27. PubMed ID: 25875025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial.
    Herrera-Arellano A; Flores-Romero S; Chávez-Soto MA; Tortoriello J
    Phytomedicine; 2004 Jul; 11(5):375-82. PubMed ID: 15330492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Hibiscus sabdariffa and Zingiber officinale on pharmacokinetics and pharmacodynamics of amlodipine.
    Alam MA; Bin Jardan YA; Alzenaidy B; Raish M; Al-Mohizea AM; Ahad A; Al-Jenoobi FI
    J Pharm Pharmacol; 2021 Aug; 73(9):1151-1160. PubMed ID: 34383955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults.
    McKay DL; Chen CY; Saltzman E; Blumberg JB
    J Nutr; 2010 Feb; 140(2):298-303. PubMed ID: 20018807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
    Malacco E; Omboni S; Mallion JM; Volpe M;
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes.
    Mozaffari-Khosravi H; Jalali-Khanabadi BA; Afkhami-Ardekani M; Fatehi F; Noori-Shadkam M
    J Hum Hypertens; 2009 Jan; 23(1):48-54. PubMed ID: 18685605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa.
    Seck SM; Doupa D; Dia DG; Diop EA; Ardiet DL; Nogueira RC; Graz B; Diouf B
    J Hum Hypertens; 2017 Dec; 32(1):75-81. PubMed ID: 29311704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J
    Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
    Kang S; Wu YF; An N; Ren M
    Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for hypertension in adults aged 18 to 59 years.
    Musini VM; Gueyffier F; Puil L; Salzwedel DM; Wright JM
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008276. PubMed ID: 28813123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure targets in adults with hypertension.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roselle for hypertension in adults.
    Pattanittum P; Ngamjarus C; Buttramee F; Somboonporn C
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD007894. PubMed ID: 34837382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
    Wong GW; Boyda HN; Wright JM
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial.
    Elkafrawy N; Younes K; Naguib A; Badr H; Kamal Zewain S; Kamel M; Raoof GFA; M El-Desoky A; Mohamed S
    Phytother Res; 2020 Dec; 34(12):3379-3387. PubMed ID: 32725873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.